title: Role of plasmapheresis as liver support for early graft dysfunction following adult living donor liver transplantation.
abstract: BACKGROUND
  Severe early graft dysfunction has been occasionally encountered following adult living donor liver transplantation (LDLT). We have assessed the effectiveness of plasmapheresis (PP) as liver support for LDLT recipients with severe early graft dysfunction.
  
  
  METHODS
  Of the 789 adult LDLTs performed between January 2007 and December 2009, 50 patients (6.3%) underwent PP as a supportive measure during the first month.
  
  
  RESULTS
  The mean time from LDLT to start of plasmapheresis was 11.2 ± 6.8 days (range 2-28). The 50 patients underwent 517 sessions of PP, or a mean of 10.3 ± 6.8 sessions per patient, over a mean 21.6 ± 9.4 days. Thirty-four patients (68%) required concurrent hemodiafiltration. Mean serum total bilirubin concentration before PP was 16.2 ± 6.7 mg/dL, peaking at 20.3 ± 7.9 mg/dL during PP, and decreasing to 13.4 ± 5.4 mg/dL 1 week after completion of PP (P < .001 compared with before PP). Except for prothrombin time, no other biochemical parameter was significantly altered by PP. There were no serious complications related to PP. Of the 50 patients, 17 (34%) died soon or a few months after PP. The 6-month graft survival rate after completion of PP was 66%; the overall 1-year patient survival rate was 64.0%.
  
  
  CONCLUSIONS
  PP appeared to have beneficial effects for LDLT recipients with severe early graft dysfunction, namely total bilirubin concentrations greater than 10 mg/dL.
authors.affiliation: Department of Surgery, Division of Hepatobiliary Surgery and Liver Transplantation, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
authors.forename: C-S
authors.initials: CS
authors.lastname: Park
authors.forename: S
authors.initials: S
authors.lastname: Hwang
authors.forename: H-W
authors.initials: HW
authors.lastname: Park
authors.forename: Y-H
authors.initials: YH
authors.lastname: Park
authors.forename: H-J
authors.initials: HJ
authors.lastname: Lee
authors.forename: J-M
authors.initials: JM
authors.lastname: Namgoong
authors.forename: S-Y
authors.initials: SY
authors.lastname: Yoon
authors.forename: S-W
authors.initials: SW
authors.lastname: Jung
authors.forename: G-C
authors.initials: GC
authors.lastname: Park
authors.forename: D-H
authors.initials: DH
authors.lastname: Jung
authors.forename: G-W
authors.initials: GW
authors.lastname: Song
authors.forename: D-B
authors.initials: DB
authors.lastname: Moon
authors.forename: C-S
authors.initials: CS
authors.lastname: Ahn
authors.forename: K-H
authors.initials: KH
authors.lastname: Kim
authors.forename: T-Y
authors.initials: TY
authors.lastname: Ha
authors.forename: S-W
authors.initials: SW
authors.lastname: Kwon
authors.forename: S-G
authors.initials: SG
authors.lastname: Lee
mesh_terms: D000328:Adult; D006085:Graft Survival; D006801:Humans; D016031:Liver Transplantation; D019520:Living Donors; D010956:Plasmapheresis; D016019:Survival Analysis